Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3021% below fair value
$49.60−1.02 (-2.02%)
Close on Nov 19, 2026Market cap $2.35BP/E 13.9Yield –
Prestige Consumer Healthcare operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Prestige Consumer Healthcare's operating income for the twelve months ending Jun 30, 2026 was $290.17M, down 13.8% year over year. For fiscal 2026 it was $309.41M, down 8.1% from the year before. Over ten years it grew 1.7% a year on average. The highest annual figure on record is $342.43M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $309.41M | -8.1% |
| FY2025 | Mar 31, 2025 | $336.78M | -1.7% |
| FY2024 | Mar 31, 2024 | $342.43M | – |
| FY2023 | Mar 31, 2023 | -$22.42M | -106.8% |
| FY2022 | Mar 31, 2022 | $329.92M | +10.9% |
| FY2021 | Mar 31, 2021 | $297.40M | +2.1% |
| FY2020 | Mar 31, 2020 | $291.16M | +331.3% |
| FY2019 | Mar 31, 2019 | $67.50M | -68.7% |
| FY2018 | Mar 31, 2018 | $215.47M | +4.8% |
| FY2017 | Mar 31, 2017 | $205.64M | -21.0% |
| FY2016 | Mar 31, 2016 | $260.32M | +25.4% |
| FY2015 | Mar 31, 2015 | $207.56M | +10.0% |
| FY2014 | Mar 31, 2014 | $188.62M | -1.7% |
| FY2013 | Mar 31, 2013 | $191.88M | +86.6% |
| FY2012 | Mar 31, 2012 | $102.82M | +35.0% |
| FY2011 | Mar 31, 2011 | $76.15M | -2.8% |
| FY2010 | Mar 31, 2010 | $78.33M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $52.52M | -26.8% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $75.49M | -14.6% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $82.49M | -10.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $79.67M | -5.5% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $71.76M | -0.4% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $88.43M | +7.6% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $91.96M | +5.9% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $84.34M | -4.4% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $72.05M | -15.4% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $82.15M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $86.83M | -0.4% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $88.25M | +4.6% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $85.19M | -2.1% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$281.00M | -462.9% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $87.18M | +5.6% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $84.38M | +7.4% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $87.01M | -4.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $77.43M | +9.1% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $82.59M | +12.5% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $78.56M | +7.8% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $91.34M | +14.0% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $70.94M | -4.0% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $73.44M | -3.9% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $72.90M | +5.1% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $80.12M | +12.1% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $73.92M | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $76.40M | -1.5% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $69.35M | -2.2% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $71.49M | -1.4% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$153.45M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $77.54M | -7.6% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $70.92M | -6.3% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $72.49M | -8.2% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$23.10M | -143.5% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $83.89M | +21.1% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $75.73M | +6.6% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $78.96M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $53.05M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $69.29M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $71.06M | – |
See a number that looks wrong?